Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma

Journal of the National Cancer Institute

Volumn 97, Issue 18, 2005, Pages 1345-1353

  Chen, Li Tzong ^a,f   Lin, Jaw Town ^b   Tai, John Jen ^a,c   Chen, Gran Hum ^d   Yeh, Hong Zen ^d   Yang, Sheng Shun ^d   Wang, Hsiu Po ^b   Kuo, Sung Hsin ^b   Sheu, Bor Shyang ^e   Jan, Chang Ming ^f   Wang, Wen Ming ^f   Wang, Tsang En ^g   Wu, Chew Wun ^h   Chen, Chi Long ⁱ   Su, Ih Jen ^a   Whang Peng, Jacqueline ^a   Cheng, Ann Lii ^b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g MACKAY MEMORIAL HOSPITAL   (Taiwan)

^h TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; EARLY CANCER; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTICENTER STUDY; NONHUMAN; PATIENT MONITORING; PERSISTENT INFECTION; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY; TREATMENT OUTCOME; COMPARATIVE STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; DRUG EFFECT; HOSPITALIZATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL; TAIWAN; TIME;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; METRONIDAZOLE; MIDDLE AGED; MULTICENTER STUDIES; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 25144464528     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji277     Document Type: Article

References (46)

1. Isaacson PG, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinct type of B-cell lymphoma. Cancer 1983;82: 1410-6.
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: The non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909-18.
3. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
4. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
5. Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-9.
6. Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-5.
7. Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 2001;86:609-17.
8. Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: An uncontrolled study. Ann Intern Med 1999;131:88-95.
9. Weston AP, Banerjee SK, Horvat RT, Zoubine MN, Campbell DR, Cherian R. Prospective long-term endoscopic and histologic follow-up of gastric lymphoproliferative disease of early stage IE low-grade B-cell mucosa-associated lymphoid tissue type following Helicobacter pylori eradication treatment. Int J Oncol 1999;15:899-907.
10. Begum S, Sano T, Endo H, Kawamata H, Urakami Y. Mucosal changes of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: Follow-up study of 48 cases. J Med Invest 2000;47:36-46.
11. Ruskone-Fourmestaux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48:297-303.
12. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: Experience from a large prospective series. Gut 2004;53:34-7.
13. Kim YS, Kim JS, Jung HC, Lee CH, Kim CW, Song IS, et al. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: Possible association with p16 hypermethylation. J Gastroenterol 2002;37:17-22.
14. Chiang IP, Wang HH, Cheng AL, Lin JT, Su IJ. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: Clinicopathologic analysis of 19 cases. J Formos Med Assoc 1996;95:857-65.
15. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-4.
16. Seymour JF, Anderson R, Bhathal PS. Regression of gastric lymphoma with therapy for Helicobacter pylori infection. Ann Intern Med 1997; 127:247.
17. Ng WW, Lam CP, Chau WK, Li FY, Huang CC, Chang FY, et al. Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy. Gastrointest Endosc 2000;51:93-6.
18. Alpen B, Robbecke J, Wundisch T, Stolte M, Neubauer A. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL). Ann Hematol 2001;80 Suppl 3:B106-7.
19. Salam I, Durai D, Murphy JK, Sundaram B. Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2001;13:1375-8.
20. Miki H, Hideo S, Harada H, Yamanoi Y, Uraoka T, Sotozono M, et al. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. J Gastroenterol 2001;36:121-4.
21. Morgner A, Miehlke S, Fischbach W, Schmitt W, Muller-Hermelink H, Greiner A, et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001;19:2041-8.
22. Montalban C, Santon A, Boixeda D, Bellas C. Regression of gastric high-grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut 2001;49:584-7.
23. Sugimoto M, Kajimura M, Sato Y, Hanai H, Kaneko E, Kobayashi H. Regression of primary gastric diffuse large B-cell lymphoma after eradication of Helicobacter pylori. Gastrointest Endosc 2001;54:643-5.
24. Gretschel S, Hunerbein M, Foss HD, Krause M, Schlag PM. Regression of high-grade gastric B-cell lymphoma after eradication of Helicobacter pylori. Endoscopy 2001;33:805-7.
25. Hiyama T, Haruma K, Kitadai Y, Ito M, Masuda H, Miyamoto M, et al. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability. Int J Oncol 2001;18: 1207-12.
26. Alsolaiman MM, Bakis G, Nazeer T, MacDermott RP, Balint JA. Five years of complete remission of gastric diffuse large B cell lymphoma after eradication of Helicobacter pylori infection. Gut 2003; 52:507-9.
27. Chen LT, Lin JT, Shyu RY, Jan CM, Chen CL, Chiang IP, et al. Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001;19:4245-51.
28. Nakamura S, Matumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, et al. Predictive value of endoscopic ultrasonography for regression of gastric low-grade and high-grade MALT lymphomas after eradication of Helicobacter pylori. Gut 2001;48:454-60.
29. Harris NL, Jaffe ES, Diebold J, Fladrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
30. Ely S. Distinction between "high grade MALT" and diffuse large B cell lymphoma of mucosa associated lymphoid tissue. Gut 2002;51:893.
31. Kahl BS. Update: Gastric MALT lymphoma. Curr Opin Oncol 2003;15: 347-52.
32. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987;11:445-62.
33. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALToma) of the stomach. Am J Pathol 1990;136:1153-64.
34. de Jong D, Aleman BM, Taal BG, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey. Ann Oncol 1999;10:275-80.
35. Musshoff K. Klinische Stadieneinteilung der nicht-Hodgkin Lymphome. Strahlenthreapie Onkol 1977;153:218-21.
36. Kaplan ER, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
37. Nakamura T, Inagaki H, Seto M, Nakamura S. Gastric low-grade B-cell MALT lymphoma: Treatment, response, and genetic alteration. J Gastroenterol 2003;38:921-9.
38. Ye H, Liu H, Raderer M, Chott A, Ruskone-Fourmestraux A, Wotherspoon A, et al. High incidence of t(11;18) (q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 2003;101:2547-50.
39. Rosenwald A, Ott G, Stilgenbauer S, Kalla J, Bredt M, Katzenberger T, et al. Exclusive deletion of the t(11;18) (q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999;155:1817-21.
40. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14) (p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999;96:35-45.
41. Maes B, Demunter A, Peeters B, De Wolf-Peeters C. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the AP12-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood 2002;99: 1398-404.
42. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FE, et al. Bcl10 and MALT1, Independent targets of chromosomal translocation in MALT Lymphoma, cooperate in a novel NF-κB signaling pathway. J Biol Chem 2001;276:19012-9.
43. Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E, et al. Translocation t(1;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000;95:4014-5.
44. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122: 1286-94.
45. Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000;156:1433-9.
46. Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004;22:3491-7.